Lyntris Sets $492M IPO Terms: Trive’s Defense-Tech Roll-Up Hits NYSE
Lyntris (NYSE: LYNX), the Accelint + Vitesse combination backed by Trive Capital, set an IPO range of $19-$22 targeting up to $528M and a ~$2.36B market cap.
Defense
Poison Pill Explained: How Shareholder Rights Plans Work
What is a poison pill? How the flip-in, flip-over, and trigger thresholds work — plus the Twitter, Airgas, and Household cases every investor should know.
Applied Aerospace IPO: $634M Defense Float Tests AADX Demand
Greenbriar-backed Applied Aerospace & Defense sets terms for a $634M NYSE IPO at a $3.33B market cap, pricing June 2 under ticker AADX.